Vita 34 AG
XETRA:V3V

Watchlist Manager
Vita 34 AG Logo
Vita 34 AG
XETRA:V3V
Watchlist
Price: 4.72 EUR Market Closed
Updated: Jun 1, 2024
V3V
/
Cash Flow Statement
/
Change in Working Capital

Vita 34 AG
Change in Working Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vita 34 AG
Change in Working Capital Peer Comparison

Comparables:
F
FME
FRE
E
1846
SYAB

Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
Vita 34 AG
XETRA:V3V
Change in Working Capital
€1.9m
CAGR 3-Years
N/A
CAGR 5-Years
78%
CAGR 10-Years
N/A
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
Change in Working Capital
-€6.7m
CAGR 3-Years
N/A
CAGR 5-Years
55%
CAGR 10-Years
16%
Fresenius SE & Co KGaA
XETRA:FRE
Change in Working Capital
€731m
CAGR 3-Years
-6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
Euroeyes International Eye Clinic Ltd
HKEX:1846
Change in Working Capital
-HK$70.9m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Synlab AG
XETRA:SYAB
Change in Working Capital
-€68.9m
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Vita 34 AG's Change in Working Capital?
Change in Working Capital
1.9m EUR

Based on the financial report for Dec 31, 2023, Vita 34 AG's Change in Working Capital amounts to 1.9m EUR.

What is Vita 34 AG's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
78%

ALPHA SPREAD
Join more than 142,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.